Literature DB >> 20694373

[Guidelines for pregnancy in the woman with heart disease].

.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20694373

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  5 in total

1.  Incidence of Adverse Drug Reactions in High-Risk Pregnancy: A Prospective Cohort Study in Obstetric Intensive Care.

Authors:  Tatiana Xavier da Costa; Marta Danielle de Almeida Pimenta Cunha; Priscilla Karilline do Vale Bezerra; Francine Johansson Azeredo; Rand Randall Martins; Antonio Gouveia Oliveira
Journal:  Eur J Clin Pharmacol       Date:  2019-11-25       Impact factor: 2.953

2.  Risk Prediction of Cardiovascular Complications in Pregnant Women With Heart Disease.

Authors:  Luciana Carvalho Martins; Claudia Maria Vilas Freire; Carolina Andrade Bragança Capuruçu; Maria do Carmo Pereira Nunes; Cezar Alencar de Lima Rezende
Journal:  Arq Bras Cardiol       Date:  2016-03-08       Impact factor: 2.000

3.  Patient Management with Metallic Valve Prosthesis during Pregnancy and Postpartum Period.

Authors:  Juliane Dantas Seabra Garcez; Vitor Emer Egypto Rosa; Antonio Sergio de Santis Andrade Lopes; Tarso Augusto Duenhas Accorsi; João Ricardo Cordeiro Fernandes; Pablo Maria Pomerantzeff; Walkiria Samuel Avila; Flavio Tarasoutchi
Journal:  Arq Bras Cardiol       Date:  2015-10       Impact factor: 2.000

4.  Case 5 / 2018 - Acute Respiratory Failure and Cardiogenic Shock in a Patient in the First Trimester of Pregnancy with Mechanical Mitral Valve Prosthesis Implant.

Authors:  Walkíria Samuel Ávila; Vinícius Araújo de Freitas Chagas Caldas; Daniel Valente Batista; Paulo Sampaio Gutierrez
Journal:  Arq Bras Cardiol       Date:  2018-10       Impact factor: 2.000

5.  Acute pulmonary edema in an obstetric intensive care unit: A case series study.

Authors:  Ana Carolina B Pordeus; Leila Katz; Mariana C Soares; Sabina B Maia; Melania M R Amorim
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.